Australia's Orthocell set for biggest gain in 7 months on Canada approval

Orthocell

11/07/2024 02:08

** Shares of regenerative medicine company Orthocell Ltd
 OCC.AX  rise as much as 9.5% to A$0.405; set for their biggest
intraday pct gain since Nov 14, if current trend holds
    ** Orthocell says Health Canada granted a medical device
licence for its product, Striate, for use in guided bone
regeneration in dental implant procedures 
    ** Stock hits highest level since May 14
    ** More than 413,815 shares change hands, thrice the 30-day
average volume 
    ** Stock has fallen 9.76% this year, as of last close


 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))